Form 4 for LTRN Lantern Pharma Inc.
Accepted 2026-05-14 16:10:08 ET · period of report 2026-05-12 · accession 0001493152-26-023082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-14 16:10 | 2026-05-12 | LTRN | KEYSER D JEFFREY | Dir | P - Purchase | $2.06 | +48.5K | 94.3K | +106% | +$100.0K |
| D | 2026-05-14 16:10 | 2026-05-12 | LTRN | KEYSER D JEFFREY | Dir | P - Purchase | $0.00 | -48.5K | 48.5K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, $0.001 par value | 2026-05-12 | P | A | 48,544 | $2.06 | 94,303 | D | — | — | (F1) The reported securities were acquired in the issuer's offering of securities that closed on May 14, 2026. The warrants are exercisable commencing on November 14, 2026. |
| 2 | Derivative | Common stock purchase warrant (Right to Buy) | 2026-05-12 | P | D | 48,544 | $0.00 | 48,544 | D | $2.27 · — to 2031-11-13 | 48,544 Common Stock | (F1) The reported securities were acquired in the issuer's offering of securities that closed on May 14, 2026. The warrants are exercisable commencing on November 14, 2026. (F1) The reported securities were acquired in the issuer's offering of securities that closed on May 14, 2026. The warrants are exercisable commencing on November 14, 2026. |